US Patent 7772250 Compounds
Patent 7772250 was granted and assigned to Theravance on August, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+183 characters)
Article
Patent abstract
This invention relates to cinnamate salts of 5-[(R)-2-(2-{4-[4-(2-amino-2-methyl-propoxy)-phenylamino]-phenyl}-ethylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Lois Elizabeth Vernon1
1
Type: Web page
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07772250 Compounds US Patent 7772250 Compounds
Infobox
Patent Number
077722501
Patent Number
77722501
1
Type: Web page
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
1
Type: Web page
Edits on 25 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077722501
Date of Patent
August 10, 2010
1Patent Application Number
113278861
Date Filed
January 9, 2006
1Official Website
Patent Primary Examiner
1
Type: Web page
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07772250 Compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07772250
Date of patent
August 10, 2010
Patent application number
11327886
Date Filed
January 9, 2006
Patent primary examiner
Find more entities like US Patent 7772250 Compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Content Issue